Chinese biotechnology company 3SBio has raised HK$5.5bn (US$711m) from its Hong Kong IPO, after pricing it at the top of its indicative range…. more
APAC Financial Markets • #3SBio, #Equities, #HongKong, #IPO #Equities, #Issuance/Pipeline
Chinese biotechnology company 3SBio has raised HK$5.5bn (US$711m) from its Hong Kong IPO, after pricing it at the top of its indicative range…. more
No comments:
Post a Comment